Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001546868 | SCV001766465 | pathogenic | not provided | 2022-12-23 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); Also known as Q719X; This variant is associated with the following publications: (PMID: 25525159, 11112658) |
Labcorp Genetics |
RCV002570673 | SCV003440767 | pathogenic | Trichorhinophalangeal syndrome, type III; Trichorhinophalangeal dysplasia type I | 2024-03-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln732*) in the TRPS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRPS1 are known to be pathogenic (PMID: 11112658). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with trichorhinophalangeal syndrome (PMID: 11112658). This variant is also known as 2155C>T (p.Q719X). ClinVar contains an entry for this variant (Variation ID: 1187428). For these reasons, this variant has been classified as Pathogenic. |